Skip to main content
. Author manuscript; available in PMC: 2013 Sep 22.
Published in final edited form as: Hepatology. 2011 Dec 14;55(2):419–428. doi: 10.1002/hep.24747

Fig. 4.

Fig. 4

Mean (SD) steady-state GS-9450 concentration-versus-time profiles. GS-9450 was quantifiable over the dosing interval for all treatment groups. Examination of the mean and median GS-9450 trough values and mean predose and 24-hour post-dose concentrations achieved during serial pharmacokinetic assessment for each group indicated that steady state had been reached by 2–4 weeks of daily dosing.